CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 333,333 shares at $1.49 ($496,666)
- 4 Open-market sale significant owner sold 21,000 shares at $2.03 ($42,609)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Significant Owner bought 238,500 shares at an average $2.12 ($504,793)
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 9,390 shares at $2.12 ($19,907)
- 4 Open-market buy Director bought 234,742 shares at $2.12 ($497,653)
- 4 Open-market buy Director bought 117,371 shares at $2.12 ($248,827)
- 4 Open-market buy President and CEO bought 46,948 shares at $2.12 ($99,530)
Page 8 of 11 · 211 filings